Investigational Drug Information for Toluene
✉ Email this page to a colleague
What is the development status for investigational drug Toluene?
Toluene is an investigational drug.
There have been 9 clinical trials for Toluene.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lymphoma, T-Cell, and Infections. The leading clinical trial sponsors are National Cancer Institute (NCI), PTS International Inc., and University of Texas Southwestern Medical Center.
Summary for Toluene
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,546 |
| WIPO Patent Applications | 2,126 |
| Japanese Patent Applications | 58 |
| Clinical Trial Progress | Phase 3 (2009-08-01) |
| Vendors | 51 |
Recent Clinical Trials for Toluene
| Title | Sponsor | Phase |
|---|---|---|
| Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate | First Affiliated Hospital of Zhejiang University | Phase 1 |
| A Phase II Study of PTS100 in Primary HCC Patients | Gongwin Biopharm Co., Ltd. | Phase 2 |
| A Study of PTS for Patients With Solid Tumors | PTS International Inc. | Phase 1 |
Clinical Trial Summary for Toluene
Top disease conditions for Toluene
Top clinical trial sponsors for Toluene
US Patents for Toluene
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
